QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was 20.3%, against 4.2% the year before. The highest annual figure on record is 22.8% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.3% | +16.1 |
| FY2024 | Dec 31, 2024 | 4.2% | −13.1 |
| FY2023 | Dec 31, 2023 | 17.4% | −2.4 |
| FY2022 | Dec 31, 2022 | 19.8% | −3.0 |
| FY2021 | Dec 31, 2021 | 22.8% | +3.6 |
| FY2020 | Dec 31, 2020 | 19.2% | +21.9 |
| FY2019 | Dec 31, 2019 | -2.7% | −15.4 |
| FY2018 | Dec 31, 2018 | 12.7% | +9.8 |
| FY2017 | Dec 31, 2017 | 2.8% | −3.2 |
| FY2016 | Dec 31, 2016 | 6.0% | −4.2 |
| FY2015 | Dec 31, 2015 | 10.2% | +1.5 |
| FY2014 | Dec 31, 2014 | 8.7% | +3.3 |
| FY2013 | Dec 31, 2013 | 5.3% | −5.0 |
| FY2012 | Dec 31, 2012 | 10.3% | +2.1 |
| FY2011 | Dec 31, 2011 | 8.2% | −5.1 |
| FY2010 | Dec 31, 2010 | 13.3% | −0.4 |
| FY2009 | Dec 31, 2009 | 13.6% | +3.7 |
| FY2008 | Dec 31, 2008 | 10.0% | – |
See a number that looks wrong?